True Global Ventures has significantly increased its investment in Prezent, nearly doubling its position through a secondary transaction, signaling continued confidence in the company’s execution, market positioning, and long-term growth trajectory. The investment coincides with the launch of Prezent Vivo, a new offering that fuses purpose-built artificial intelligence with expert services to deliver enterprise communication outcomes, with a clear focus on the life sciences industry. Prezent has grown more than 200% in annual recurring revenue year-over-year and is currently in a scale-up phase, making it one of the strongest-performing companies in True Global Ventures’ portfolio.
Prezent is trusted by more than 150 life sciences organizations, including 45 of the world’s leading biopharma companies, and has completed over 5 million deliverables across the sector. The company has built its reputation by earning trust through individual deliverables rather than broad platform promises, and says it is now entering a new phase of growth with Prezent Vivo as the vehicle for that expansion. The Vivo offering integrates AI technology with domain expertise to address the growing demand for outcome-driven solutions in complex, regulated industries where communication quality and scientific rigor are both essential.
True Global Ventures believes Prezent Vivo reflects a broader shift across the AI landscape, where value creation increasingly depends on the integration of technology, services, and domain-specific intelligence rather than technology alone. The firm describes a compounding dynamic in which each interaction between a client and the AI-plus-services model strengthens the system, deepens the data advantage, and ultimately delivers more meaningful outcomes — particularly in sectors like life sciences where the complexity of the subject matter makes generic AI tools insufficient. Prezent Vivo is designed so that BioPharma companies and the agencies that serve them no longer have to choose between speed, scientific rigor, and cost-effectiveness.
True Global Ventures is a global venture capital firm investing in post-revenue, AI-first companies, with a current portfolio that includes Forge Global, Obligo, COVU, Ledger, and Animoca Brands, among others. The firm operates across San Francisco, New York, Paris, London, Stockholm, Dubai, Singapore, and Hong Kong, and focuses on backing visionary founders building the next generation of transformative technology companies. With strong momentum behind both its existing platform and the Vivo launch, Prezent is positioning itself to further expand its reach beyond life sciences into other complex enterprise sectors.
KEY QUOTES:
“Prezent Vivo fuses purpose-built AI and human expertise in one integrated experience — for BioPharma and the Agencies that serve them. Life Sciences companies don’t have to choose between fast, scientifically rigorous and cost-effective anymore — with Vivo you get all three.”
Rajat Mishra, CEO, Prezent
“We believe the most powerful AI models are those that combine technology and services. This creates a compounding dynamic where each interaction strengthens the system, deepens the data advantage, and ultimately delivers more meaningful outcomes for customers, particularly in complex sectors such as Life Sciences.”
Frank Desvignes, Founding Partner, True Global Ventures
